US Stock MarketDetailed Quotes

Adicet Bio (ACET)

Watchlist
  • 8.220
  • +0.170+2.11%
Close Apr 17 16:00 ET
  • 8.350
  • +0.130+1.58%
Post 19:00 ET
78.88MMarket Cap-0.48P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Adicet Bio (ACET) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-3.10%-95.25M
13.24%-20.91M
-1.37%-22.31M
-13.71%-26.63M
-11.15%-25.4M
1.43%-92.38M
-2.62%-24.1M
-3.62%-22.01M
5.93%-23.42M
5.17%-22.85M
Net income from continuing operations
0.27%-116.8M
-6.23%-30.52M
11.88%-26.86M
-4.40%-31.22M
-0.71%-28.21M
17.90%-117.12M
2.58%-28.73M
38.90%-30.48M
7.72%-29.9M
9.28%-28.02M
Operating gains losses
--103K
--0
--0
----
----
----
----
----
----
----
Depreciation and amortization
-1.35%6.38M
-9.24%1.47M
-1.19%1.57M
3.31%1.66M
1.76%1.68M
6.07%6.47M
-3.91%1.62M
-3.22%1.59M
6.09%1.6M
31.66%1.65M
Other non cash items
5.87%3.43M
28.47%1.06M
-15.28%682K
4.41%828K
5.39%860K
12.60%3.24M
7.87%822K
7.48%805K
1.02%793K
41.18%816K
Change In working capital
126.66%1.47M
1,381.55%2.64M
211.90%470K
103.02%58K
43.10%-1.7M
-2,292.46%-5.53M
84.80%-206K
-134.12%-420K
-1,132.26%-1.92M
-1,667.89%-2.98M
-Change in prepaid assets
232.26%1.68M
184.25%1.19M
-1,975.76%-619K
122.78%347K
481.00%762K
-237.26%-1.27M
146.47%419K
-94.21%33K
-5,339.29%-1.52M
-193.46%-200K
-Change in payables and accrued expense
420.20%2.93M
748.86%2.24M
344.42%1.75M
24.45%509K
20.93%-1.57M
1.82%-916K
135.39%264K
-72.21%394K
-58.14%409K
23.20%-1.98M
-Change in other current assets
-12.75%308K
-94.74%4K
33.33%116K
-10.20%88K
8.70%100K
-1.40%353K
-18.28%76K
-1.14%87K
5.38%98K
9.52%92K
-Change in other current liabilities
6.56%-3.45M
17.51%-796K
16.70%-778K
1.99%-886K
-11.37%-989K
-3,628.28%-3.69M
-10.67%-965K
-10.53%-934K
-5.61%-904K
-135.89%-888K
Cash from discontinued investing activities
Operating cash flow
-3.10%-95.25M
13.24%-20.91M
-1.37%-22.31M
-13.71%-26.63M
-11.15%-25.4M
1.43%-92.38M
-2.62%-24.1M
-3.62%-22.01M
5.93%-23.42M
5.17%-22.85M
Investing cash flow
Cash flow from continuing investing activities
102.01%2.39M
-101.33%-44.54M
117.43%16.84M
11,011.59%32.95M
-1,097.07%-2.86M
-2,571.19%-119.24M
-16,164.71%-22.12M
-10,560.15%-96.58M
79.96%-302K
87.52%-239K
Net PPE purchase and sale
-55.46%-1.74M
105.68%10K
47.88%-209K
84.44%-47K
-524.27%-1.49M
74.96%-1.12M
-29.41%-176K
55.74%-401K
79.96%-302K
87.52%-239K
Net investment purchase and sale
103.50%4.13M
-102.99%-44.55M
117.72%17.05M
--33M
---1.37M
---118.12M
---21.94M
---96.18M
--0
--0
Cash from discontinued investing activities
Investing cash flow
102.01%2.39M
-101.33%-44.54M
117.43%16.84M
11,011.59%32.95M
-1,097.07%-2.86M
-2,571.19%-119.24M
-16,164.71%-22.12M
-10,560.15%-96.58M
79.96%-302K
87.52%-239K
Financing cash flow
Cash flow from continuing financing activities
-32.40%75.25M
54,813.87%75.23M
-150K
30.88%267K
-100.09%-104K
47,063.98%111.31M
80.26%137K
0
-9.73%204K
1,585,328.57%110.97M
Net issuance payments of debt
---150K
--0
----
----
----
--0
--0
----
----
----
Net common stock issuance
-32.23%75.17M
--75.17M
--0
--0
--0
--110.92M
--0
--0
--0
--110.92M
Proceeds from stock option exercised by employees
-38.30%327K
-56.20%60K
--0
30.88%267K
--0
37.31%530K
-12.74%137K
--0
-9.73%204K
6,200.00%189K
Net other financing activities
26.24%-104K
--0
--0
--0
26.24%-104K
6.00%-141K
--0
--0
--0
-1,310.00%-141K
Cash from discontinued financing activities
Financing cash flow
-32.40%75.25M
54,813.87%75.23M
---150K
30.88%267K
-100.09%-104K
47,063.98%111.31M
80.26%137K
--0
-9.73%204K
1,585,328.57%110.97M
Net cash flow
Beginning cash position
-62.81%59.4M
-69.66%32M
-83.21%37.62M
-87.46%31.04M
-62.81%59.4M
-38.01%159.71M
-42.44%105.48M
9.06%224.07M
6.89%247.59M
-38.01%159.71M
Current changes in cash
82.45%-17.61M
121.24%9.79M
95.26%-5.62M
128.01%6.59M
-132.27%-28.36M
-2.42%-100.31M
-95.72%-46.08M
-434.10%-118.59M
10.16%-23.52M
437.78%87.88M
End cash Position
-29.64%41.79M
-29.64%41.79M
-69.66%32M
-83.21%37.62M
-87.46%31.04M
-62.81%59.4M
-62.81%59.4M
-42.44%105.48M
9.06%224.07M
6.89%247.59M
Free cash flow
-3.73%-96.98M
13.91%-20.9M
-0.49%-22.52M
-12.46%-26.68M
-16.46%-26.89M
4.77%-93.5M
-2.77%-24.28M
-1.19%-22.41M
10.16%-23.72M
11.23%-23.09M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -3.10%-95.25M13.24%-20.91M-1.37%-22.31M-13.71%-26.63M-11.15%-25.4M1.43%-92.38M-2.62%-24.1M-3.62%-22.01M5.93%-23.42M5.17%-22.85M
Net income from continuing operations 0.27%-116.8M-6.23%-30.52M11.88%-26.86M-4.40%-31.22M-0.71%-28.21M17.90%-117.12M2.58%-28.73M38.90%-30.48M7.72%-29.9M9.28%-28.02M
Operating gains losses --103K--0--0----------------------------
Depreciation and amortization -1.35%6.38M-9.24%1.47M-1.19%1.57M3.31%1.66M1.76%1.68M6.07%6.47M-3.91%1.62M-3.22%1.59M6.09%1.6M31.66%1.65M
Other non cash items 5.87%3.43M28.47%1.06M-15.28%682K4.41%828K5.39%860K12.60%3.24M7.87%822K7.48%805K1.02%793K41.18%816K
Change In working capital 126.66%1.47M1,381.55%2.64M211.90%470K103.02%58K43.10%-1.7M-2,292.46%-5.53M84.80%-206K-134.12%-420K-1,132.26%-1.92M-1,667.89%-2.98M
-Change in prepaid assets 232.26%1.68M184.25%1.19M-1,975.76%-619K122.78%347K481.00%762K-237.26%-1.27M146.47%419K-94.21%33K-5,339.29%-1.52M-193.46%-200K
-Change in payables and accrued expense 420.20%2.93M748.86%2.24M344.42%1.75M24.45%509K20.93%-1.57M1.82%-916K135.39%264K-72.21%394K-58.14%409K23.20%-1.98M
-Change in other current assets -12.75%308K-94.74%4K33.33%116K-10.20%88K8.70%100K-1.40%353K-18.28%76K-1.14%87K5.38%98K9.52%92K
-Change in other current liabilities 6.56%-3.45M17.51%-796K16.70%-778K1.99%-886K-11.37%-989K-3,628.28%-3.69M-10.67%-965K-10.53%-934K-5.61%-904K-135.89%-888K
Cash from discontinued investing activities
Operating cash flow -3.10%-95.25M13.24%-20.91M-1.37%-22.31M-13.71%-26.63M-11.15%-25.4M1.43%-92.38M-2.62%-24.1M-3.62%-22.01M5.93%-23.42M5.17%-22.85M
Investing cash flow
Cash flow from continuing investing activities 102.01%2.39M-101.33%-44.54M117.43%16.84M11,011.59%32.95M-1,097.07%-2.86M-2,571.19%-119.24M-16,164.71%-22.12M-10,560.15%-96.58M79.96%-302K87.52%-239K
Net PPE purchase and sale -55.46%-1.74M105.68%10K47.88%-209K84.44%-47K-524.27%-1.49M74.96%-1.12M-29.41%-176K55.74%-401K79.96%-302K87.52%-239K
Net investment purchase and sale 103.50%4.13M-102.99%-44.55M117.72%17.05M--33M---1.37M---118.12M---21.94M---96.18M--0--0
Cash from discontinued investing activities
Investing cash flow 102.01%2.39M-101.33%-44.54M117.43%16.84M11,011.59%32.95M-1,097.07%-2.86M-2,571.19%-119.24M-16,164.71%-22.12M-10,560.15%-96.58M79.96%-302K87.52%-239K
Financing cash flow
Cash flow from continuing financing activities -32.40%75.25M54,813.87%75.23M-150K30.88%267K-100.09%-104K47,063.98%111.31M80.26%137K0-9.73%204K1,585,328.57%110.97M
Net issuance payments of debt ---150K--0--------------0--0------------
Net common stock issuance -32.23%75.17M--75.17M--0--0--0--110.92M--0--0--0--110.92M
Proceeds from stock option exercised by employees -38.30%327K-56.20%60K--030.88%267K--037.31%530K-12.74%137K--0-9.73%204K6,200.00%189K
Net other financing activities 26.24%-104K--0--0--026.24%-104K6.00%-141K--0--0--0-1,310.00%-141K
Cash from discontinued financing activities
Financing cash flow -32.40%75.25M54,813.87%75.23M---150K30.88%267K-100.09%-104K47,063.98%111.31M80.26%137K--0-9.73%204K1,585,328.57%110.97M
Net cash flow
Beginning cash position -62.81%59.4M-69.66%32M-83.21%37.62M-87.46%31.04M-62.81%59.4M-38.01%159.71M-42.44%105.48M9.06%224.07M6.89%247.59M-38.01%159.71M
Current changes in cash 82.45%-17.61M121.24%9.79M95.26%-5.62M128.01%6.59M-132.27%-28.36M-2.42%-100.31M-95.72%-46.08M-434.10%-118.59M10.16%-23.52M437.78%87.88M
End cash Position -29.64%41.79M-29.64%41.79M-69.66%32M-83.21%37.62M-87.46%31.04M-62.81%59.4M-62.81%59.4M-42.44%105.48M9.06%224.07M6.89%247.59M
Free cash flow -3.73%-96.98M13.91%-20.9M-0.49%-22.52M-12.46%-26.68M-16.46%-26.89M4.77%-93.5M-2.77%-24.28M-1.19%-22.41M10.16%-23.72M11.23%-23.09M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -